Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, September 2, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8979 POSTS
0 Comments
https://bostonlifesciencestimes.com
Public Health
Global Covid-19 cases surpass 74.8 million: Johns Hopkins
Life Sciences Times
-
December 18, 2020
0
Public Health
New study strongly suggests Covid-19 enters brain
Life Sciences Times
-
December 18, 2020
0
Pharma
India to produce 300 million doses of the Russian Sputnik V vaccine in 2021: Report
Life Sciences Times
-
December 18, 2020
0
Public Health
Study reveals why women face less severe Covid-19 complications
Life Sciences Times
-
December 18, 2020
0
Public Health
Higher intake of ultra-processed foods may up death risk
Life Sciences Times
-
December 18, 2020
0
Venture Capital
Cirtec Medical Announces Acquisition of NovelCath
Life Sciences Times
-
December 17, 2020
0
Venture Capital
Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms
Life Sciences Times
-
December 17, 2020
0
Venture Capital
ECS Awarded $28.8 Million USMC IT Service and Support Contract
Life Sciences Times
-
December 17, 2020
0
Medtech
Cedar Gate Technologies Acquires Lexington-Based Deerwalk
Life Sciences Times
-
December 17, 2020
0
Biotech
Ginkgo Bioworks Acquires Biotechnology Startup Novogy
Life Sciences Times
-
December 17, 2020
0
1
...
890
891
892
...
898
Page 891 of 898
TOP AUTHORS
Life Sciences Times
8979 POSTS
0 Comments
https://bostonlifesciencestimes.com
Most Read
Treeline, Roche to Test TLN-121 With Bispecific Antibodies in B-Cell Lymphomas
September 2, 2026
RevBio Study Finds TETRANITE Promotes Bone Regeneration in Microgravity
September 2, 2026
Elucid Raises $55 Million to Expand AI-Powered Cardiovascular Imaging Platform
September 2, 2026
Scholar Rock Gets FDA Fast Track Designation for Apitegromab in FSHD as Phase 2 Trial Begins
September 2, 2026